Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Manuel Gargallo
Drugs in the Treatment of Obesity: Sibutramine, Orlistat and Rimonabant
Public Health Nutrition
Nutrition
Dietetics
Public Health
Environmental
Medicine
Occupational Health
Related publications
Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
Drug Safety
Toxicology
Pharmacology
Combinations of Drugs in the Treatment of Obesity
Pharmaceuticals
Molecular Medicine
Pharmaceutical Science
Weight Reduction and Long-Term Maintenance After 18 Months Treatment With Orlistat for Obesity
International Journal of Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Comparison of the Central Action of Drugs for Medical Treatment of Obesity
Obesity and Metabolism
Internal Medicine
Nutrition
Endocrinology
Public Health
Environmental
Dietetics
Occupational Health
Metabolism
Diabetes
Melanotropins as Drugs for the Treatment of Obesity and Other Feeding Disorders: Potential and Problems
Current Topics in Medicinal Chemistry
Medicine
Drug Discovery
Crystal Structure of Pathogenic Staphylococcus Aureus Lipase Complex With the Anti-Obesity Drug Orlistat
Scientific Reports
Multidisciplinary
A Common Variant in the Adiponectin Gene on Weight Loss and Body Composition Under Sibutramine Therapy in Obesity
Clinical Pharmacology: Advances and Applications
Pharmacology
FDA Approval of Obesity Drugs
JAMA - Journal of the American Medical Association
Medicine
Sibutramine and L-Carnitine Compared to Sibutramine Alone on Insulin Resistance in Diabetic Patients
Internal Medicine
Internal Medicine
Medicine